These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25163591)

  • 21. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome.
    Kingma DW; Mueller BU; Frekko K; Sorbara LR; Wood LV; Katz D; Raffeld M; Jaffe ES
    Arch Pathol Lab Med; 1999 Jan; 123(1):83-7. PubMed ID: 9923843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
    Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
    Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Wu Q; Ren F; Elston DM
    Cutis; 2019 Nov; 104(5):297-300. PubMed ID: 31886782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy.
    Kim DH; Kim M; Kim Y; Han K; Han E; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e497-e500. PubMed ID: 28697169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.
    Zheng X; Xie J; Zhou X
    Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
    J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
    Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
    Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
    Kawamoto K; Miyoshi H; Suzuki T; Kozai Y; Kato K; Miyahara M; Yujiri T; Choi I; Fujimaki K; Muta T; Kume M; Moriguchi S; Tamura S; Kato T; Tagawa H; Makiyama J; Kanisawa Y; Sasaki Y; Kurita D; Yamada K; Shimono J; Sone H; Takizawa J; Seto M; Kimura H; Ohshima K
    Haematologica; 2018 Jun; 103(6):1018-1028. PubMed ID: 29242302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder.
    Yamamoto T; Shirakawa A; Kawaguchi M; Masuda A; Nishikawa T; Kobayashi M
    Ann Hematol; 2004 Feb; 83(2):127-32. PubMed ID: 14530876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].
    Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population.
    Murga-Zamalloa C; Stone MB; Gutierrez MG; Hippalgaonkar NR; Tariq H; Sadeh M; Mehta A; Khan I; Alkan S; Inamdar KV; Wilcox R; Behdad A
    Am J Clin Pathol; 2024 Jun; 161(6):586-597. PubMed ID: 38345307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
    Zeng Y; Fu L; Jin H; Sun Q; Wang B
    Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
    Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
    Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Intestinal Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease.
    Wang Z; Zhang W; Luo C; Zhu M; Zhen Y; Mu J; Zhang Y; Hu R; Wang Y; Wen Z; Ouyang Q; Xiao S; Zhang H
    J Crohns Colitis; 2018 Jul; 12(8):896-904. PubMed ID: 29635312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
    Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
    Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
    Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
    Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
    Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.